PresentationKallum TitchmarshEquity Analyst Okay. Great. I think we can get started, everyone. Kallum Titchmarsh here from the Life Sciences team at Morgan Stanley. Really pleased today to be joined by Helmy Eltoukhy, Chairman, Co-Founder and Co-CEO; AmirAli Talasaz, Co-Founder and Co-CEO; and we have Mike Bell, CFO as well with us. So before we get started, I have to read you some disclosures. So please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. So mayb ...

Anglo American is nearing a deal to acquire Canadian miner Teck Resources , Bloomberg News reported on Monday, citing people with knowledge of the matter. ...

The Murdoch family on Monday resolved the legal battle over control of its media empire, which includes Fox Corp. and News Corp, the company said.Lachlan Murdoch — the executive chairman and CEO of Fox Corp. and chairman of News Corp — will maintain control of the media giant forged by his 94-year-old father, Rupert Murdoch.Under the terms of the deal, a new trust called LGC Holdco LLC, will be established for the benefit of Lachlan Murdoch, and his younger sisters Grace and Chloe Murdoch. 4 The Murdoch f ...

PresentationGreat. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. Very pleased to be hosting Biogen this morning. We have Chris Viehbacher, the company's CEO. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Chris, thanks so much for joining us this morning ...

It's time for the final trade. Michael Co. Michael.Yeah, I still like Robin Hood, but I think if you want to get a little more yield out of it, think about selling some upside covered calls. Timote. Yeah, I like this breakout in China Tech.I think Baba is the way you're most confident right now. Dan Nathan, I hate when you call me Daniel. I'm usually in trouble a little bit.Yeah. No, that digital story is kind of interesting. Double digit earnings growth, 8 uh 83% gross margin.So, Jen looks interesting. ...

Source: TradingView.com. Close Key Takeaways Robinhood Markets (HOOD) shares soared Monday on news that the retail trading platform known for commission-free stock trading will be added to the benchmark S&P 500 index. Late Friday, S&P Global said Robinhood, along with mobile app monetization company AppLovin (APP) and navigation systems maker Emcor Group (EME), would join the large cap index, with the inclusions taking effect before the beginning of trading on Sept. 22. Stocks that join the S&P 500 typicall ...

The rise was due almost entirely to an external development with its shares.For stock investors, one way to prosperity on Monday was by having a position in medical tech company Waystar (WAY 9.63%). After all, it was an outlier in the best way possible, since it shares zoomed almost 10% skyward on news that it'll be a component in a popular stock index.That gain was particularly impressive, as the benchmark S&P 500 (^GSPC 0.21%) bumped only 0.2% higher.That's one way to gain more prominenceThat index is the ...

The company is about to be pushed forward by some strong tailwinds, one pundit believes.It was more than smooth sailing for the stock of maritime logistics specialist Scorpio Tankers (STNG 10.63%) on Monday. A recommendation upgrade from an analyst at a very well-known bank powered the company's equity that trading session, sending it to a nearly 11% increase at market close. That trounced the S&P 500 index's 0.2% bump higher.Higher rates prompt bullish revisionThat analyst is Ken Hoexter of Bank of America ...

PresentationSo thanks again, everyone, for joining us for the fireside chat with Whitehawk Therapeutics. I'm joined today by CEO, Dave Lennon. Dave, great to have you here. Before we get -- as we get started, could you give us an overview of Whitehawk and your strategic focus across your three ADC candidates?All right. Good afternoon, everyone. My name is Frank Tang and I'm with the investment banking division at Morgan Stanley. Before we get started, I'd like to read a quick disclaimer. For important discl ...

PresentationYujiro HataFounder, President, CEO & Director Welcome to all of our attendees to IDEAYA's 10-year anniversary R&D Day. Today marks an important milestone in the company's history, and we want to thank each of you for sharing this special day with us. I hope everyone will walk away feeling inspired by the extraordinary R&D ongoing at IDEAYA and the strategic vision that will drive forward our growth as a global leader in precision medicine oncology in the coming decade. Please note, we'll be maki ...